Yep the key points say it all I believe @turps :
Key Points:
TPM® Oxymorphone Patch pre-IND, FDA face-to-face meeting confirmed for December ‘18.
Injectable candidates continue to progress – development candidates on track for 2018 Tox
Multiple companies undertaking due diligence on Animal Health Business.
Strong Vital ET sales on forecast for 2018
Independent research coverage rates POH a ‘Buy’ with target 8-9 cents share price
Mylan Arbitration Outcome: still to come.
Ann: Phosphagenics Newsletter - August 2018, page-3
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $973 | 486.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 6361102 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 41925822 | 29 |
View Market Depth
| Last trade - 10.27am 31/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |